Peter Charlton

Peter retired from the position of Vice President of Biology at Vertex Pharmaceuticals in 2014. In that role, he had line management of the UK Biology Division and was responsible for Protein Biochemistry, Crystallography/Structural Biology, Cell Biology, Enzymology, and Pharmacology and for the development of the UK Research Portfolio from target identification through to nomination of clinical candidates. Peter obtained a DPhil in Chemistry and Enzymology from the University of Sussex and he has worked across many therapeutic areas including oncology, neurodegenerative disease, sepsis, and multiple sclerosis. He has a long history of working in biotech and pharma, including Xenova Group plc for 13 years, latterly as the Head of Biology. Prior to that, he was a Senior Research Leader at GlaxoSmithKline for 8 years. Peter is an Honorary Professor at the University of Warwick.